Abiopharma

Clinical trial NCT07549490: start date: 2026-08-11 → 2026-08-12.

General Announcement: RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2026

Clinical trial NCT04433065 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2031-07-30 → 2031-08-26 3. primary completion date: 2026-07-30 → 2026-09-10

Clinical trial NCT03105102 updates: 1. completion date: 2026-05-01 → 2029-02-01 2. primary completion date: 2026-05-01 → 2029-02-01

Clinical trial NCT06056050 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-09-28 → 2025-03-11 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06884865 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. primary completion date: 2032-07-01 → 2026-11-01

Clinical trial NCT06983691: start date: 2026-07-01 → 2026-08-01.

Clinical trial NCT07459660: status: RECRUITING → ENROLLING_BY_INVITATION.

Clinical trial NCT01728571 updates: 1. completion date: 2025-02-01 → 2027-11-01 2. primary completion date: 2018-11-10 → 2018-10-11 3. collaborators added: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), National Center for Complementary and Integrative Health (NCCIH)

Clinical trial NCT03135886 updates: 1. completion date: 2026-07-31 → 2026-08-31 2. primary completion date: 2026-01-31 → 2026-08-31